Tech Company Financing Transactions
BioStable Funding Round
BioStable secured a $5.5 million Series A funding round on 12/15/2008. Investors included Sante Ventures.
Transaction Overview
Company Name
Announced On
12/15/2008
Transaction Type
Venture Equity
Amount
$5,500,000
Round
Series A
Investors
Sante Ventures (Joseph Cunningham)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2621 Ridgepoint Dr. 100
Austin, TX 78754
USA
Austin, TX 78754
USA
Phone
Website
Email Address
Overview
BioStable develops innovative new products for the treatment of cardiovascular diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
John Wheeler
VP - Bus. Development
Thomas Williamson
VP - Operations
Julie Thomas
Browse more venture capital transactions:
Prev: 12/15/2008: SensorTran venture capital transaction
Next: 12/15/2008: Worksoft venture capital transaction
Share this article
Where The Data Comes From
We report on funding rounds that are announced publicly. VC transactions on this site are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs